[go: up one dir, main page]

CY2431B1 - Novel phenanthridines substituted in the 6 position. - Google Patents

Novel phenanthridines substituted in the 6 position.

Info

Publication number
CY2431B1
CY2431B1 CY0400018A CY0400018A CY2431B1 CY 2431 B1 CY2431 B1 CY 2431B1 CY 0400018 A CY0400018 A CY 0400018A CY 0400018 A CY0400018 A CY 0400018A CY 2431 B1 CY2431 B1 CY 2431B1
Authority
CY
Cyprus
Prior art keywords
novel
substituted
phenanthridines substituted
novel phenanthridines
compounds
Prior art date
Application number
CY0400018A
Other languages
English (en)
Inventor
Hermann Amschler
Dieter Flockerzi
Wolf-Ruediger Ulrich
Thomas Baer
Thomas Martin
Christian Schudt
Armin Hatzelmann
Rolf Beume
Dietrich Haefner
Hildegard Boss
Hans-Peter Kley
Beate Gutterer
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996113091 external-priority patent/DE19613091A1/de
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CY2431B1 publication Critical patent/CY2431B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • C07D221/12Phenanthridines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
CY0400018A 1996-03-26 2004-03-12 Novel phenanthridines substituted in the 6 position. CY2431B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19611922 1996-03-26
EP96105038 1996-03-29
DE1996113091 DE19613091A1 (de) 1996-04-02 1996-04-02 6-Phenylphenanthridine
EP96105311 1996-04-03

Publications (1)

Publication Number Publication Date
CY2431B1 true CY2431B1 (en) 2004-11-12

Family

ID=27438318

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400018A CY2431B1 (en) 1996-03-26 2004-03-12 Novel phenanthridines substituted in the 6 position.

Country Status (12)

Country Link
EP (1) EP0889886B1 (pt)
JP (1) JP4141501B2 (pt)
AT (1) ATE224386T1 (pt)
AU (1) AU718752B2 (pt)
CA (1) CA2250569C (pt)
CY (1) CY2431B1 (pt)
DE (1) DE59708265D1 (pt)
DK (1) DK0889886T5 (pt)
ES (1) ES2184077T3 (pt)
PT (1) PT889886E (pt)
SI (1) SI0889886T1 (pt)
WO (1) WO1997035854A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE04054B1 (et) * 1997-07-25 2003-06-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrasoolderivaadid, nende kasutamine ravimite valmistamiseks ja neid sisaldav ravim
DK1000035T3 (da) * 1997-07-25 2003-03-17 Altana Pharma Ag Substituerede 6-phenylphenanthridiner
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
IT1296985B1 (it) 1997-12-19 1999-08-03 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
WO2000042034A1 (en) * 1999-01-15 2000-07-20 Byk Gulden Phenanthridine-n-oxides with pde-iv inhibiting activity
CZ300366B6 (cs) * 1999-01-15 2009-05-06 Nycomed Gmbh Fenylfenanthridinová sloucenina, farmaceutický prostredek s jejím obsahem a její použití
ES2242594T3 (es) * 1999-01-15 2005-11-16 Altana Pharma Ag N-oxidos de fenantridinas con una acitvidad inhidora de pde-iv.
WO2000042019A1 (en) * 1999-01-15 2000-07-20 Byk Gulden Lomberg Chemische Fabrik Gmbh 6-arylphenanthridines with pde-iv inhibiting activity
DE60033918D1 (de) * 1999-01-15 2007-04-26 Altana Pharma Ag Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
JP2003519686A (ja) * 2000-01-11 2003-06-24 アルタナ ファルマ アクチエンゲゼルシャフト フェナントリジン−n−オキシド
AU2001269126A1 (en) * 2000-07-14 2002-01-30 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Phenanthridine n-oxides
WO2002006238A1 (en) * 2000-07-14 2002-01-24 Altana Pharma Ag Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
AU2001281965A1 (en) * 2000-07-14 2002-01-30 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Novel 6-phenylphenanthridines
AU8393501A (en) 2000-07-14 2002-01-30 Byk Gulden Lomberg Chem Fab Novel 6-heteroarylphenanthridines
US7329676B2 (en) 2002-08-29 2008-02-12 Nycomed Gmbh 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
DE60311662T2 (de) 2002-08-29 2007-10-25 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
EP1624893A2 (en) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Inhibitors of phosphodiesterases in infertility
EP1658271A1 (en) * 2003-07-31 2006-05-24 ALTANA Pharma AG Novel 6-phenylphenanthridines
US20060189645A1 (en) * 2003-07-31 2006-08-24 Altana Pharma Ag Novel 6-phenylphenantridines
JP4728259B2 (ja) 2004-02-18 2011-07-20 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 効果的なホスホジエステラーゼ(pde)4インヒビターとしての新規のグアニジニル置換されたヒドロキシ−6−フェニルフェナントリジン
CA2557752C (en) 2004-03-03 2012-10-02 Altana Pharma Ag Hydroxy-6-heteroaryl-phenanthridines and their use as pde4 inhibitors
BRPI0508361A (pt) * 2004-03-09 2007-11-20 Altana Pharma Ag hidróxi-6-fenilfenantridinas substituìdas por isoamido
US20080161339A1 (en) * 2004-03-10 2008-07-03 Altana Pharma Ag Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors
JP2007527898A (ja) * 2004-03-10 2007-10-04 アルタナ ファルマ アクチエンゲゼルシャフト ジフルオロエトキシ置換された新規のヒドロキシ−6−フェニルフェナントリジン及びpde4インヒビターとしてのそれらの使用
US20080119505A1 (en) 2005-02-01 2008-05-22 Altana Pharma Ag Novel 6-Pyridylphenanthridines
RS51345B (en) 2005-03-02 2011-02-28 Nycomed Gmbh (2R, 4aR, 10bR) -6- (2,6-DIMETOXYPYRIDIN-3-IL) -9-ETOXY-8-METHOXY-1,2,3,4,4a, 10b-Hexahydrophenanthridin-2-OL, HCl SO
JP2008531654A (ja) * 2005-03-02 2008-08-14 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 炎症性疾患の治療のためのPDE4インヒビターとしての6−ヘテロアリール−1,2,3,4,4a,10b−ヘキサヒドロフェナントリジン
BRPI0615102A2 (pt) * 2005-08-30 2011-05-03 Abbott Lab composto, composições farmacêuticas como inibidores de dipeptidil peptidase-iv (dpp-iv), bem como uso
UY35543A (es) * 2013-04-30 2014-11-28 Bayer Cropscience Ag N-(fenilcicloalquil)carboxamidas y n-(fenilcicloalquil)tiocarboxamidas nematicidas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786031A (fr) * 1971-07-08 1973-01-08 Rhone Poulenc Sa Nouveaux derives de la phenanthridine, leur preparation et les compositions medicinales qui les contiennent
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Also Published As

Publication number Publication date
DK0889886T3 (da) 2003-01-20
WO1997035854A1 (de) 1997-10-02
CA2250569C (en) 2005-05-10
EP0889886A1 (de) 1999-01-13
JP2000507256A (ja) 2000-06-13
JP4141501B2 (ja) 2008-08-27
DK0889886T5 (da) 2003-02-24
ATE224386T1 (de) 2002-10-15
PT889886E (pt) 2003-02-28
EP0889886B1 (de) 2002-09-18
DE59708265D1 (de) 2002-10-24
AU2291097A (en) 1997-10-17
AU718752B2 (en) 2000-04-20
CA2250569A1 (en) 1997-10-02
ES2184077T3 (es) 2003-04-01
SI0889886T1 (en) 2003-02-28

Similar Documents

Publication Publication Date Title
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
CY2473B1 (en) New phenanthridines.
PL338339A1 (en) Novel derivatives of tetrazole
MX9700557A (es) Dihidrobenzofuranos.
CA2297911A1 (en) Substituted 6-phenylphenanthridines
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
CY2582B2 (en) New imidazopyridines and oxazolopyridines